Haim Bio Co., Ltd.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| MTD, Safety and Efficacy of NYH817G and NYH100P in Monotherapy and Combination in Patients With Advanced Solid Tumors (NCT04262739) | Haim Bio Co., Ltd. | 2019-12-18 |
Track Haim Bio Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.